Change - Announcement of Appointment::Redesignation of Group Chief Commercial and Strategy Officer to Group Chief Strategy Officer

Issuer & Securities

Issuer/ Manager
NANOFILM TECHNOLOGIES INTERNATIONAL LIMITED
Securities
NANOFILM TECHNOLOGIES INTL LTD - SGXE61652363 - MZH
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
11-Jun-2023 17:37:28
Status
New
Announcement Sub Title
Redesignation of Group Chief Commercial and Strategy Officer to Group Chief Strategy Officer
Announcement Reference
SG230611OTHRK59N
Submitted By (Co./ Ind. Name)
Lim Kian Onn
Designation
Chief Financial Officer
Description (Please provide a detailed description of the event in the box below)
Redesignation of Group Chief Commercial and Strategy Officer to Group Chief Strategy Officer of Nanofilm Technologies International Limited (the ''Company'' or ''NTI'')

Additional Details

Date Of Appointment
15/06/2023
Name Of Person
Gian Yi Hsen
Age
47
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board has considered the Nominating Committee's recommendation and assessment of the qualifications of Mr Gian Yi Hsen (''Mr Gian'') and his extensive experience and expertise in global strategic investment promotion, technology solutions identification and incubation as well as enterprise transformation, and has approved the redesignation of Mr Gian as Group Chief Strategy Officer.

The appointment of Mr Ian Howe as Chief Commercial Officer (as announced) and the redesignation of Mr Gian as Chief Strategy Officer are part of the Company's continuous efforts to enhance its organizational structure and collective capability to drive business growth.
Whether appointment is executive, and if so, the area of responsibility
Executive. The primary areas of responsibility are to oversee and execute the Group's corporate strategies, including merger & acquisition activities to support its inorganic growth. In addition, Mr Gian will manage the Group's risk management systems and sustainability processes, as well as its operations in Japan.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Group Chief Strategy Officer
Professional qualifications
Bachelor of Electrical and Electronic Engineering - University of Tokyo (2001)
EDB - Glaxo Scholarship (1995)
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
2022 - Present: NTI, Group Chief Commercial and Strategy Officer
June 2021 - December 2021: NTI, Deputy Chief Executive Officer, Strategy & Planning
May 2021 - June 2021: NTI, Vice President, Strategy & Planning
2018 - May 2021: Economic Development Board of Singapore (EDB), Senior Vice President, Head of Conglomerate
2018: EDB, Cleantech & Cities, Infrastructure & Industrial Solutions, Executive Director
2015 - 2018: EDB, Regional President of Americas
2010 - 2015: EDB, Director of Industry Identification & Incubation
2013 - 2015: EDB, Chief Information Officer
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
21,000 ordinary shares in the capital of the Company
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
None
Present
1. Nanofilm Technologies International Limited
2. Miller Technologies Pte. Ltd.
3. Nanofilm Advanced Materials Pte. Ld.
4. Nanofab Technologies Pte. Ltd.
5. Nanofilm Vacuum Coating (Shanghai) Co., Ltd
6. Nanofilm Renewable Energy Technology (Shanghai) Co., Ltd
7. Yizheng Nahuan Technologies Co., Ltd
8. Nanofilm Technologies Japan Limited
9. Nanofab Japan Co., Ltd
10. Nanofilm Advanced Materials Co., Ltd
11. Nanofab Vietnam Co., Ltd
12. Wizture Holdings Pte. Ltd.
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not applicable
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable